P. Brogan Et Al. , "PAEDIATRIC OPEN-LABEL CLINICAL STUDY OF RITUXIMAB FOR THE TREATMENT OF GRANULOMATOSIS WITH POLYANGIITIS (GPA) AND MICROSCOPIC POLYANGIITIS (MPA)," Congress of the European-League-Against-Rheumatism (EULAR) , vol.77, Amsterdam, Netherlands, pp.212, 2018
Brogan, P. Et Al. 2018. PAEDIATRIC OPEN-LABEL CLINICAL STUDY OF RITUXIMAB FOR THE TREATMENT OF GRANULOMATOSIS WITH POLYANGIITIS (GPA) AND MICROSCOPIC POLYANGIITIS (MPA). Congress of the European-League-Against-Rheumatism (EULAR) , (Amsterdam, Netherlands), 212.
Brogan, P., Cleary, G., Kasapcopur, O., Rangaraj, S., Yeung, R., Brunetta, P., ... Cooper, J.(2018). PAEDIATRIC OPEN-LABEL CLINICAL STUDY OF RITUXIMAB FOR THE TREATMENT OF GRANULOMATOSIS WITH POLYANGIITIS (GPA) AND MICROSCOPIC POLYANGIITIS (MPA) . Congress of the European-League-Against-Rheumatism (EULAR) (pp.212). Amsterdam, Netherlands
Brogan, P. Et Al. "PAEDIATRIC OPEN-LABEL CLINICAL STUDY OF RITUXIMAB FOR THE TREATMENT OF GRANULOMATOSIS WITH POLYANGIITIS (GPA) AND MICROSCOPIC POLYANGIITIS (MPA)," Congress of the European-League-Against-Rheumatism (EULAR), Amsterdam, Netherlands, 2018
Brogan, P. Et Al. "PAEDIATRIC OPEN-LABEL CLINICAL STUDY OF RITUXIMAB FOR THE TREATMENT OF GRANULOMATOSIS WITH POLYANGIITIS (GPA) AND MICROSCOPIC POLYANGIITIS (MPA)." Congress of the European-League-Against-Rheumatism (EULAR) , Amsterdam, Netherlands, pp.212, 2018
Brogan, P. Et Al. (2018) . "PAEDIATRIC OPEN-LABEL CLINICAL STUDY OF RITUXIMAB FOR THE TREATMENT OF GRANULOMATOSIS WITH POLYANGIITIS (GPA) AND MICROSCOPIC POLYANGIITIS (MPA)." Congress of the European-League-Against-Rheumatism (EULAR) , Amsterdam, Netherlands, p.212.
@conferencepaper{conferencepaper, author={P. Brogan Et Al. }, title={PAEDIATRIC OPEN-LABEL CLINICAL STUDY OF RITUXIMAB FOR THE TREATMENT OF GRANULOMATOSIS WITH POLYANGIITIS (GPA) AND MICROSCOPIC POLYANGIITIS (MPA)}, congress name={Congress of the European-League-Against-Rheumatism (EULAR)}, city={Amsterdam}, country={Netherlands}, year={2018}, pages={212} }